Literature DB >> 23000194

Over-expression of human endosulfatase-1 exacerbates cadmium-induced injury to transformed human lung cells in vitro.

Huiying Zhang1, Donna R Newman, James C Bonner, Philip L Sannes.   

Abstract

Environmental exposure to cadmium is known to cause damage to alveolar epithelial cells of the lung, impair their capacity to repair, and result in permanent structural alterations. Cell surface heparan sulfate proteoglycans (HSPGs) can modulate cell responses to injury through their interactions with soluble effector molecules. These interactions are often sulfate specific, and the removal of sulfate groups from HS side chains could be expected to influence cellular injury, such as that caused by exposure to cadmium. The goal of this study was to define the role 6-O-sulfate plays in cellular responses to cadmium exposure in two pulmonary epithelial cancer cell lines (H292 and A549) and in normal human primary alveolar type II (hAT2) cells. Sulfate levels were modified by transduced transient over-expression of 6-O-endosulfatase (HSulf-1), a membrane-bound enzyme which specifically removes 6-O-sulfate groups from HSPG side chains. Results showed that cadmium decreased cell viability and activated apoptosis pathways at low concentrations in hAT2 cells but not in the cancer cells. HSulf-1 over-expression, on the contrary, decreased cell viability and activated apoptosis pathways in H292 and A549 cells but not in hAT2 cells. When combined with cadmium, HSulf-1 over-expression further decreased cell viability and exacerbated the activation of apoptosis pathways in the transformed cells but did not add to the toxicity in hAT2 cells. The finding that HSulf-1 sensitizes these cancer cells and intensifies the injury induced by cadmium suggests that 6-O-sulfate groups on HSPGs may play important roles in protection against certain environmental toxicants, such as heavy metals.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23000194      PMCID: PMC3489971          DOI: 10.1016/j.taap.2012.09.008

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  32 in total

Review 1.  Heparan sulfate proteoglycans: intricate molecules with intriguing functions.

Authors:  R V Iozzo
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 2.  Tumorigenic and adhesive properties of heparanase.

Authors:  Flonia Levy-Adam; Neta Ilan; Israel Vlodavsky
Journal:  Semin Cancer Biol       Date:  2010-07-07       Impact factor: 15.707

3.  Cadmium-induced apoptosis of primary epithelial lung cells: involvement of Bax and p53, but not of oxidative stress.

Authors:  M Lag; S Westly; T Lerstad; C Bjørnsrud; M Refsnes; P E Schwarze
Journal:  Cell Biol Toxicol       Date:  2002       Impact factor: 6.691

Review 4.  Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.

Authors:  Uri Barash; Victoria Cohen-Kaplan; Ilana Dowek; Ralph D Sanderson; Neta Ilan; Israel Vlodavsky
Journal:  FEBS J       Date:  2010-08-31       Impact factor: 5.542

5.  SULFs in human neoplasia: implication as progression and prognosis factors.

Authors:  Caroline Bret; Jérôme Moreaux; Jean-François Schved; Dirk Hose; Bernard Klein
Journal:  J Transl Med       Date:  2011-05-21       Impact factor: 5.531

6.  Periplocin inhibits growth of lung cancer in vitro and in vivo by blocking AKT/ERK signaling pathways.

Authors:  Ze J Lu; Yan Zhou; Qi Song; Zhao Qin; Hong Zhang; Yong J Zhou; Lan T Gou; Jin L Yang; Feng Luo
Journal:  Cell Physiol Biochem       Date:  2010-10-29

Review 7.  Novel roles for ceramides, calpains and caspases in kidney proximal tubule cell apoptosis: lessons from in vitro cadmium toxicity studies.

Authors:  Wing-Kee Lee; Frank Thévenod
Journal:  Biochem Pharmacol       Date:  2008-07-11       Impact factor: 5.858

8.  Carcinogenicity of inhaled vanadium pentoxide in F344/N rats and B6C3F1 mice.

Authors:  N B Ress; B J Chou; R A Renne; J A Dill; R A Miller; J H Roycroft; J R Hailey; J K Haseman; J R Bucher
Journal:  Toxicol Sci       Date:  2003-05-28       Impact factor: 4.849

Review 9.  Heparan sulfate proteoglycans: structure, protein interactions and cell signaling.

Authors:  Juliana L Dreyfuss; Caio V Regatieri; Thais R Jarrouge; Renan P Cavalheiro; Lucia O Sampaio; Helena B Nader
Journal:  An Acad Bras Cienc       Date:  2009-09       Impact factor: 1.753

10.  HSULF-1 inhibits ERK and AKT signaling and decreases cell viability in vitro in human lung epithelial cells.

Authors:  Huiying Zhang; Donna R Newman; Philip L Sannes
Journal:  Respir Res       Date:  2012-08-08
View more
  4 in total

Review 1.  Plasma membrane wounding and repair in pulmonary diseases.

Authors:  Xiaofei Cong; Rolf D Hubmayr; Changgong Li; Xiaoli Zhao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-06       Impact factor: 5.464

2.  Heparin and LPS-induced COX-2 expression in airway cells: a link between its anti-inflammatory effects and GAG sulfation.

Authors:  Na Young Yi; Donna R Newman; Huiying Zhang; Helena Morales Johansson; Philip L Sannes
Journal:  Exp Lung Res       Date:  2015       Impact factor: 2.459

3.  Epithelial Heparan Sulfate Contributes to Alveolar Barrier Function and Is Shed during Lung Injury.

Authors:  Sarah M Haeger; Xinyue Liu; Xiaorui Han; J Brennan McNeil; Kaori Oshima; Sarah A McMurtry; Yimu Yang; Yilan Ouyang; Fuming Zhang; Eva Nozik-Grayck; Rachel L Zemans; Rubin M Tuder; Julie A Bastarache; Robert J Linhardt; Eric P Schmidt
Journal:  Am J Respir Cell Mol Biol       Date:  2018-09       Impact factor: 7.748

4.  In vitro toxicity evaluation of engineered cadmium-coated silica nanoparticles on human pulmonary cells.

Authors:  Uliana De Simone; Luigi Manzo; Antonella Profumo; Teresa Coccini
Journal:  J Toxicol       Date:  2013-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.